Related Experiment Video

Updated: Jan 25, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.5K

Pediatric discharge against medical advice

Emad Al-Mohammadi1

  • 1Department of Public Health Administration, Ministry of Health Saudi Arabia, Saudi Board in Community Medicine, Jeddah, Saudi Arabia.

International Journal of Health Care Quality Assurance
|April 25, 2019
PubMed

Insights

Discharges against medical advice (DAMA) in pediatric patients often stem from parental misunderstanding or dissatisfaction, leading to higher readmission rates. Understanding these factors is crucial for developing interventions to protect children from negative outcomes.

Area of Science:

  • Pediatric Healthcare
  • Patient Safety
  • Health Services Research

Background:

  • Discharges against medical advice (DAMA) represent a significant challenge in pediatric healthcare.
  • Understanding the specific reasons and consequences of DAMA is essential for improving patient outcomes and healthcare system efficiency.

Purpose of the Study:

  • To identify the primary reasons for pediatric discharges against medical advice (DAMA).
  • To investigate the outcomes associated with DAMA in pediatric patients.
  • To inform the development of interventions aimed at reducing DAMA rates and improving pediatric care.

Main Methods:

  • A retrospective cohort study was conducted in two maternity and children's hospitals in Jeddah.
  • Data were collected through medical record reviews and semi-structured phone interviews with DAMA and control groups.
  • The study analyzed data from 2014, comparing pediatric patients discharged against medical advice with a control group.

Main Results:

  • The leading causes for DAMA were parental belief in child's improvement (43.8%), dissatisfaction with the medical team (16.2%), and challenges with sibling care arrangements (7.7%).
  • Pediatric patients discharged against medical advice had a significantly higher 30-day readmission rate (28.5%) compared to the control group (11.5%).

Conclusions:

  • Parental misconceptions and dissatisfaction are key drivers of pediatric DAMA.
  • Higher readmission rates following DAMA underscore the need for targeted interventions.
  • Addressing the identified reasons for DAMA can lead to improved patient safety and reduced negative consequences for pediatric patients.
Abstract

Keywords:
Discharge against medical adviceMaternityPediatricSaudi Arabia

More Related Videos

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

21.1K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.2K

Related Concept Videos

Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
1.3K
RC Circuits: Discharging A Capacitor01:27

RC Circuits: Discharging A Capacitor

One of the applications of an RC circuit is the relaxation oscillator. The relaxation oscillator comprises a voltage source, a capacitor, a resistor, and a neon lamp. The lamp acts like an open circuit (infinite resistance) until the potential difference across the neon lamp reaches a specific voltage. At that voltage, the lamp acts like a short circuit (zero resistance), and the capacitor discharges through the neon lamp and produces light. Once the capacitor is fully discharged through the...
4.4K
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
769
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
200